Thieme Publishing Group is pleased to announce the launch of Pharmaceutical Substances Version 3.2. Available via Thiemeconnect, Pharmaceutical Substances is a comprehensive reference guide to every significant pharmaceutical compound and includes all FDA approved active pharmaceutical ingredients (APIs).

Fifteen drugs have been added to the upgraded version of the information resource, bringing the total of APIs to 2,475. Recent additions include Novartis new anti Malaria drug Riamet, the Japanonly available antipsychotic drug, Lonasen from Sumitomo Pharma and Evoltra, Bioenvisions new Leukemia treatment. And the monograph for Dexrazoxane has been updated with new synthetic routes.

“We strive to keep Pharmaceutical Substances as current as possible. With this update, important drugs that were approved in the last two years, but not yet covered in the product, have been added,” says Dr. Thomas Krimmer, who is in charge of Pharmaceutical Substances at Thieme. “The update is available from midMay for the users of Thiemes structure and full text searchable standalone electronic version and from the end of this month for the users of the STN version.”

Compiled by leaders in the field of pharmaceutical chemistry, in association with InfoChem and FIZ Chemie, the online version of the information resource is an easytonavigate, webbased portal that utilizes standard browser technology. The userfriendly interface enables users to rapidly locate data and graphically search structures.